isoxazoles has been researched along with Liposarcoma, Myxoid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abou Merhi, R; Agaimy, A; Al-Halabi, R; Aman, P; Gali-Muhtasib, H; Haller, F; Huebner, K; Schneider-Stock, R; Steinmann, S | 1 |
1 other study(ies) available for isoxazoles and Liposarcoma, Myxoid
Article | Year |
---|---|
Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Liposarcoma, Myxoid; MAP Kinase Signaling System; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Resorcinols; Time Factors; Xenograft Model Antitumor Assays | 2015 |